PRINCIPLES OF
ANTIBIOTIC USE IN
ICU
Dr. R.K.Sisodia
Senior Consultant
Critical care
Kailash Hospital Ltd
Greater Noida
INTRODUCTION-
--THE MODERN AGE OF ANTIBIOTIC
THERAPEUTICS WAS LAUNCHED IN 1930S
WITH SULPHONAMIDES AND IN 1940S WITH
PENICILLINS.
--SINCE THEN MANY ANTIBIOTIC DRUGS
HAVE BEEN DEVELOPED MOSLTY AIMED
AT
THE TREATMENT OF BACTERIAL
INFECTIONS.
--THESE DRUGS HAVE PLAYED AN
IMPORTANT ROLE IN THE DRAMATIC
DECREASE IN THE MORBADITY AND
MORTALITY DUE TO INFECTIOUS
DISEASES.
--WHILE THE ABSOLUTE NUMBER OF
ANTIBIOTIC DRUGS ARE LARGE, THERE
ARE FEW UNIQUE ANTIBIOTIC TARGETS
DEFINATION
ANTIBIOTICS ARE THE
TYPES OF MEDICATION
THAT DESTROYS OR
SLOWS DOWN THE
GROWTH OF BACTERIA
QUALITIES OF A GOOD ANTIBIOTIC
AGENT
-KILL OR INHIBIT THE GROWTH OF
MICROORGANISM.
-CAUSE NO DAMAGE TO THE HOST.
-CAUSE NO ALLERGIC REACTION TO THE
HOST.
-STABLE ON STORAGE.
-REMAIN IN SPECIFIC TISSUE ENOUGH TO BE
EFFECTIVE.
-KILL THE PATHOGEN BEFORE THEY MUTATE
AND BECOME RESISTANT TO IT.
WITHIN THE LAST 15 YEARS
A VARIETY OF NEW ANTIBIOTICS HAS
BEEN INTRODUCED FOR USE IN
CLINICAL PRACTICE
BUT
THE IDEAL ANTIBIOTIC MAY STILL BE IN
FUTURE…
MAIN ANTIBIOTICS USED IN ICU
DESPITE THE AVAILABILITY
OF
NUMEROUS ANTIBIOTICS,
MOST PATHOGENS ARE
OPTIMALLY TREATED
WITH ONLY A FEW DRUGS
THESE ARE A BROAD CLASS OF ANTIBIOTICS
THAT CONTAIN A BETA LACTUM RING IN THEIR
MOLECULAR STRUCTURE…
Ex- PENICILLINS
CEPHALOSPORINS
CARBAPENUMS
MONOBECTUMS
BETA LACTAMS:
--BETA LACTUM ANTIBIOTICS ARE THE MOST
WIDELY USED GROUP OF ANTIBIOTICS,
--BACTERIA OFTEN DEVELOP RESISTANCE BY
SYNTHESIZING A BETA LACTAMASE, AN
ENZYME THAT ATTACKS BETA LACTUM RING
--TO OVERCOME THIS RESISTANCE THESE
ANTIBIOTICS ARE PRESCRIBED WITH THE
BETA LACTUM INHIBITORS…
PENICILLINS
NATURAL PENICILLINS-
Ex- BENZYLPENICILLINS
-PHENOXYMETHYLPENICILLIN
SEMISYNTHETIC PENICILLINS
1-ANTISTAPHYLOCOCCI PENICILLINASE
RESISTANT PENICILLIN
Ex- OXACILLIN, DICLOXACILLIN,METHICILLIN
2-ANTIPSEUDOMONAS PENICILLINS
Ex-PIPERACILLIN
3-WIDE SPECTRUM
Ex-AMPICILLIN, AMOXICILLIN
BETA LACTAMASE INHIBITORS
-CLAVULANIC ACID
-SULBACTAM
-TAZOBACTAM
BETA-LACTAMASE PROTECTED
PENICILLINS
AMOXICILLIN / CLAVULANATE
AMPICILLIN / SUBACTUM
TICARCILLIN / CLAVULANATE
PIPERACILLIN / TAZOBACTUM
CEPHALOSPORINS:
1ST GENERATION:-
Ex-CEPHAZOLIN
CEPHALOTHIN
CEPHALORIDINE
2ND GENERATION:-
Ex-CEFAMYCIN C
CEFOXITIN
CEFOTITAN
CEFMETAZOLE
CEPHALOSPORINS:
3RD GENERATION:-
Ex-CEFTRIAXONE
-CEFOTAXIME
-CEFTAZIDIME
4TH GENERATION:-
Ex-CEFEPIME
-CEFPIROME
CEPHALOSPORINES ARE NOT
RECOMMONDED TO COMBINE WITH
OTHER NEPHROTOXIC DRUGS
(AMINOGLYCOSIDES)
CEPHALOSPORINES ARE
CONTRADICTED TO COMBINE WITH
LOOP DIURETICS...
CARBAPENUMS:
ACT BY INHIBITING THE CELL WALL
SYNTHESIS AND ARE KNOWN TO BE MOST
EFFECTIVE AGAINST GRAM NEGATIVE
INFECTION.
Ex- IMIPENUM
MERUPENUM
DORIPENUM
ERTAPENUM
THE WIDEST SPECTRUM OF
ANTIBACTERIAL ACTION
MOST OF AEROBE AND
ANAEROBE, GRAM +VE AND
GRAM –VE BACTERIA
INCLUDING THOSE WHICH
PRODUCE BETA-LACTAMASE
FLOUROQUINILONES:
EXERT THEIR ANTIBACTERIAL EFFECT BY
PREVENTING BACTERIAL DNA FROM
DUPLICATIONG.
Ex-CIPROFLOXACIN
-LEVOFLOXACIN
-OFLOXACIN
-PAZUFLOXACIN
-SPARFLOXACIN
-MOXIFLOXACIN
MACROLIDES:
-THE MECHANISM OF ACTION OF
MACROLIDES IS INHIBITION OF BACTERIAL
PROTEIN BIOSYNTHESIS.
-THIS ACTION IS BACTEROSTATIC.
CLASSIFICATION OF MACROLIDES
1- NATURAL SUBSTANCES
Ex- ERYTHROMYCIN
2- SEMI-SYNTHETIC SUBSTANCES
Ex-CLARITHROMYCIN
3- AZALIDE
Ex- AZITHROMYCIN
AMINOGLYCOSIDES:
-MAINLY GRAM NEGATIVE BACTERICIDAL
AGENT WORK BY INHIBITING PROTEIN
BIOSYNTHESIS.
1st GENERATION-
Ex-STREPTOMYCIN, NEOMYCIN,KENAMYCIN
2ND GENERATION-
Ex-GENTAMICIN, TOBRAMYCIN
3RD GENERATION-
Ex- AMIKACIN, NETILMICIN
GLYCOPEPTIDES:
- THESE DRUGS INHIBIT THE SYNTHESIS
OF CELL WALL.
- DUE TO TOXICITY THEIR USE IS
RESTRICTED TO PATIENTS WHO HAVE
HYPERSENSITIVE TO BETA LACTUMS.
- EFFECTIVE MAINLY AGAINT GRAM
POSITIVE COCCI.
Ex- VANCOMYCIN
- TEICOPLANIN
MONOBACTUM-
AZTREONUM -
-ACTION SPECTRUM- GRAM NEGATIVE
BACTERIA INCLUDING E-COLI, KLEBSIELLA.
HAEMOPHILLUS INFLUEZAE…
-ACTIVITY EQUAL TO 3RD GENERATION
CEPHALOSPORINES…
-CLINCAL USES- SEPSIS, UTI, SSTI,
MENINGITIS
-OFTENCOMBINEAMINOGLYCOSIDES,
CLINDAMYCIN,
METRONIDAZOLE,VANCOMYCIN….
LINCOSAMIDES-
CLINDAMYCIN
-ACTION SPECTRUM:
GRAM+VE AEROBIC COCCI,
GRAM+VE & GRAM –VE ANAEROBES
-PENETRATE ALL THE TISSUES
-A LOT OF SIDE EFFECTS
CLASSIFICATION
OF
ANTIBIOTICS
ACCORDING TO ACTIVITY1-BACTERICIDAL:
THEY KILL BACTERIA DIRECTLY.
Ex- BETA LACTUMS
CEPHALOSPORINS
CARBAPENUMS
AMINOGLYCOSIDES.......
2-BACTERIOSTATIC:
THEY STOP BACTERIA FROM GROWING.
Ex- TETRACYCLINE
CHLORAMPHENICOL
SULPHONAMIDES
MACROLIDES
LINCOSAMIDES
ACCORDING TO SPECTRUM
1-BROAD SPECTRUM:
THEY WORK AGAINST VARIETY OF BACTERIA
Ex:- PENICILLINS
CARBAPENUMS
FLOROQUINILONES
CEPHALOSPORINS...............
2-NARROW SPECTRUM:
THEY WORK AGAINST A SMALL RANGE OF BACTERIA
Ex:- MACROLIDES
LINCOSAMIDES
GLYCOPEPTIDES.........
ACCORDING TO MECHANISM
OF ACTION
1-CELL WALL SYNTHESIS INHIBITORS:
Ex:- PENICILLINS
CEPHALOSPORINS
BETA LACTUMS
CARBAPENUMS
MACROLIDES
VANCOMYCIN........
2- PROTEIN SYNTHESIS INHIBITORS:
A-INHIBIT 30S SUBUNIT:-
Ex- AMINOGLYCOSIDES
TETRACYCLINE
B-INHIBIT 50S SUBUNIT:-
Ex- MACROLIDES
- CHLORAMPHENICOL
- CLINDAMYCIN
- LINEZOLID
3- DNA SYNTHESIS INHIBITORS:
Ex- FLOROQUINOLONES
- METRONIDAZOLE
4- RNA SYNTHESIS INHIBITORS:
Ex- RIFAMPICIN
5- FOLIC ACID SYNTHESIS INHIBITORS:
Ex- SULPHONAMIDES
- TRIMETHOPRIM
ACCORDING TO FREQUENCY OF DOSING
1- TIME DEPENDENT
Ex- CARBAPENUMS
- MACROLIDES
- BETA LACTUMS
2- CONCENTRATION DEPENDENT
Ex- AMINOGLYCOSIDES
GLYCYLCYCLINES:
TIGICYCLINE
---SPECTRUM INCLUDED GRAM+VE AND
GRAM –VE AEROBIC AND ANAEROBIC
BACTERIA,INCLUDING SOME WITH
RESISTANT TO OTHER CLASSES e.g.
VRE, MRSA AND MDR ACINETOBACTER.
---BUT HAS LIMITED ACTIVITY AGAINST
P. AERUGINOSA.
RIGHT TIME
1- EMPIRICALLY-
FOR PRESUMED INFECTION WITH
CULTURE REPORT PENDING.
2- PROPHYLECTALLY-
MAINLY PEROPERATIVELY TO
PREVENT INFECTION.
3-DEFINITIVELY-
WITH POSITIVE CULTURE REPORT.
EMPIRICAL ANTIBIOTIC THERAPY
- IN CRITICALLY ILL PATIENTS, EMPIRICAL
ANTIBIOTIC THERAPY SHOULD BE
INITIATED IMMEDIATELY
OR
CONCURRENTLY WITH COLLECTION OF
DIAGNOSTIC SPECIMENS.
GUIDELINES
EMPIRICAL ANTIBIOTIC THERAPY
1- SITE OF INFECTION
2- PATIENT'S FACTORS
RENAL
HEPATIC
IMMUNE SYSTEM
AGE
3-SEFTY OF ANTIBIOTIC
4-COST OF THERAPY
USING ANTIBIOTICS RESPONSIBILY
RIGHT DOSE WITH RIGHT
FREQUENCY:
MONOTHERAPY
OR
COMBINATION THERAPY
ADVANTAGES
OF
COMBINATION THERAPY
1- PREVENTION OF DEVELOPMENT OF
ANTIBIOTIC RESISTANCE.
2- ACHIEVING ANTIBIOTIC SYNERGISM
Ex- SULPHONAMIDE+ TRIMETHOPRIM
- VANCOMYCIN+ AMINOGLYCOSIDE
3- WIDE ANTIBIOTIC COVERAGE
4- DECREASED INCIDENCE OF TOXICITY
GENERAL PRINCILES OF ANTIBIOTIC
THERAPY
USING ANTIBIOTICS RESPONSIBLY
RIGHT DRUG
RIGHT TIME
RIGHT DOSE
RIGHT DURATION
DISADVANTAGES OF COMBINATION
THERAPY
1- INCREASED COST OF THERAPY.
2- MORE CHANCES OF SUPERINFECTION.
3- DRUG ANTAGONISM
Ex- IF TWO BETA LACTUMS GIVEN TO
GETHER ONE WILL BECOME INEFFECTIVE
4- DIRECT INTERACTION OF DRUGS.
Ex- MIXING TICARCILLIN WITH AMONO-
GLYCOSIDE RESULTS IN INACTIVATION
OF AMINOGLYCOSIDE.
USING ANTIBIOTICS RESPONSIBLY
TIME DEPENDENT
OR
CONCENTRATION
DEPENDENT
TIME DEPENDENT DOSING
THOSE CLASSES OF ANTIBIOTICS WHOSE
KILLING RESPONSE IS DEPENDENT ON TIME
ARE TERMED AS TIME DEPENDENT
ANTIBIOTICS. HIGHER CONCENTRATION OF
SUCH DRUGS DOES NOT RESULTS IN
HIGHER KILLING OF BACTERIA.
Ex- CARBAPENUMS
- PENICILLINS
- CEPHALOSPORINS.......
CONCENTRATION DEPENDENT DOSING
THOSE CLASSES OF ANTIBIOTICS
WHICH EREDICATE BACTERIA BY
ACHIEVING HIGH CONCENTRATION
AT THE SITE OF BONDING IS KNOWN
AS CONCENTRATION DEPENDENT
ANTIBIOTICS.
Ex- AMINOGLYCOSIDES
FLOUROQUINOLONES
USING ANTIBIOTICS RESPONSIBLY
RIGHT DURATION OF THERAPY
ASCALATION
OR
DEASCALATION THERAPY
ASCALATION OR TRADITIONAL
APPROACH
TRADITIONAL APPROACH TO ANTIBIOTIC
THERAPY SUGGESTS THAT YOU SHOULD
CHOOSE THE NARROWEST SPECTRUM
ANTIBIOTIC AGAINST THE BACTERIA YOU
SUSPECT ARE CAUSING THE INFECTION.
THIS WOULD THEN BE MODIFIED BASED
ON DEFINITIVE CULTURE RESULTS.
EMPIRICAL
ANTIBIOTIC
THERAPY
ACCORDING
TO
SITE
OF
INFECTION
CENTRAL NERVOUS SYSYEM
MENINGITIS;
CEFTRIAXONE- 2 GM IV q12h
+
VANCOMYCIN- 500-750 MG IV q6h
ALTERNATIVE
MERUPENUM 2 GM IV q8h
POST HEAD TRAUMA:
CEFEPIME 2 GM IV q8h
+
VANCOMYCIN 500-750 MG IV q6h
ALTERNATIVE
MERUPENUM 2 GM IV
q8h
VANCOMYCIN 1 GM IV q6-8h
PNEUMONIA
COMMUNITY ACQUIRED:
CEFTRIAXONE 1 GM IV q12h
+
AZITHROMYCIN 500 MG IV q24h
OR
ERTAPENUM 1 GM IV q24h
+
AZITHROMYCIN 500 MG IV q24h
PNEUMONIA
HOSPITAL ACQUIRED:
IMIPENUM- 500 MG IV q6h
OR
MERUPENAM- 1 GM IV q8h
OR
DORIPENUM- 500 MG IV q8h
+
LEVO 750 MG IV q24h
OR
MOXI 400 MG IV q24h
ASPIRATION PNEUMONITIS:
-PIP+TAZO 4.5 GM IV q8h
ALTERNATIVE
CEFTRIAXONE 1 GM IV q12h
+
METRONIDAZOLE 500 MG IV q8h
PERITONITIS
SPONTANEOUS BACTERIAL PERITONITIS
CEFOTAXIME 2 GM IV q8h
OR
PIP+TAZO 4.5GM IV q8h
OR
CEFTRIOXONE 2GM IV q8h
OR
ERTAPENUM 1GM IV q24h
PERITONITIS
PERFORATION PERITONITIS
PIP+TAZO 4.5GM IV q8h
OR
ERTAPENUM 1GM IV q24h
LIFE THREATENING PERITONITIS
IMIPENUM 500MG IV q8h
OR
MERUPENUM 1GM IV q8h
OR
DORIPENUM 500MG IV q8h
BURN WOUND SEPSIS-
PIP+TAZO 4.5GM IV q8h
+
VANCOMYCIN 1 GM IV q12h
+
AMIKACIN 7.5GM / KG IV q12h
BONE AND JOINT INFECTION:
--FLUCLOXACILLIN 2 GM IV q8h
IF ALLERGIC TO PINICILLINS
--CEFUROXIME 2GM IV q8h
OR
---CLINDAMYCIN 600MG IV q6h
IF MRSA IS A POSSIBILITY
---PIP+TAZO 4.5GM IV q8h
+
----VANCOMYCIN 1GM IV q8h
IF RISK OF MDRGNB
---MERUPENUM 1GM IV q8h
TYPHOIDAL SYNDROME
CIPROFLOX 500MG IV q12h
OR
LEVOFLOX 500 MG IV q12h
OR
CEFTRIAXONE 2 GM IV q8h
OR
AZITHROMYCIN 500 MG PO q24h
INAPPROPRIATE USE OF ANTIBIOTICS
IS A WORLD WIDE PROBLEM
* MORE THAN 50% OF ALL MEDICINES ARE
PRESCRIBED,DISPENSED OR SOLD
INAPPROPRIATELY.
* HALF OF ALL PATIENTS FAIL TO TAKE MEDICINES
CORRECTLY.
*THE OVERUSE,UNDER USE OR MISUSE
HARM PEOPLE AND WASTE RESOURSES.
*MORE THAN 50% OF ALL COUNTRIES DO
NOT IMPLEMENT BASIC POLICIES TO PROMOTE
RATIONAL USE OF MEDICINES.
*LESS THAN 30% OF ALL PATIENTS ARE TREATED
ACCORDING TO CLINICAL GUIDELINES.
WHAT WENT WRONG WITH ANTIBIOTIC
USES
-TREATING TRIVIAL / VIRAL INFECTIONS
WITH ANTIBIOTICS HAS BECOME ROUTINE.
- MANY USE ANTIBIOTICS WITHOUT KNOWING
THE
BASIC PRINCIPLES OF ANTIBIOTIC THERAPY.
- MANY PRACTIONERS ARE UNDER PRESSURE
FOR SHORT TERM SOLUTIONS.
-EMERGING RESISTANCE DUE TO
UNAPPROPRIATE USE OF ANTIBIOTICS.
-COMMERCIAL INTERESTS OF PHARMACEUTICAL
INDUSTRY PUSHING THE USE OF ANTIBIOTICS.
NEED FOR NEWER
ANTIBIOTICS
NEWER ANTIBIOTICS ARE
NEEDED DESPERATELYBECAUSE:
-- EMERGENCE BACTERIAL
RESISTANCE
--RESERGENCE AND NEW
INFECTIOUS DISEASES
SINCE 2000
ONLY 3 NEW CLASSES OF ANTIBIOTICS
HAVE BEEN
INTRODUCED FOR HUMAN USE..
NEW CLASSES OF ANTIBIOTICS:
1- OXAZOLIDIONE
LINEZOLID:
-APPROVED FOR ADULT USE IN 2000.
-NEWER OXAZOLIDIONE IN PIPELINE.
RADEZOLID
TOREZOLID
NEWER CLASSES OF ANTIBIOTICS
2-LIPOPEPTIDES
-DEPTOMYCIN
APPROVED IN 2003
RAPIDLY BACTERICIDAL
NO CROSS RESISTANCE
NEWER CLASSES OF ANTIBIOTICS
3-KETOLIDES
TELITHROMYCIN
-APPROVED IN 2004
-FOR COMMUNITY
ACCQUIRED PNEUMONIA
WHY WE NEED
ANTIBIOTIC POLICY
- REDUCE THE ANTIBIOTIC RESISTANCE
- INITIATE BEST EFFORTS IN THE
HOSPITAL AREA AS MANY RESISTANCE
BACTERIA GENERATED IN HOSPITALS.
-INITIATE GOOD HYGIENIC PRACTICES
SO BACTERIA DO NOT SPREAD.
-PRACTICE BEST EFFORTS TO PREVENT
SPREAD OF RESISTANT STRAINS.
-TO PREVENT SPILL INTO SOCIETY AS
THEY PRESENT AS COMMUNITY
ACQIURED INFECTIONS.
A MEDICAL DOCTOR HAS TO KNOW
DEFINITE CLINICAL PHARMACOLOGY
OF
ANTIBIOTICS
HOW TO SELECT
AND
USE
THEM RATIONALLY
TENETS
OF
APPROPRIATE
ANTIBIOTIC
USE
TENET-1
TREAT
INFECTION
NOT
COLONIZATION
MANY PATIENTS BECOME COLONIZED
WITH POTENTIALLY PATHOGENIC
BACTERIA BUT ARE NOT INFECTED-
--ASYMPTOMATIC BACTERIURIA OR CATHETER
COLONIZATION.
---TRACHEOSTOMY COLONIZATION.
---CHRONIC WOUNDS.
---CHRONIC BRONCHITIS.
---PRESENCE OF WBC NOT ALWAYS INDICATIVE OF
INFECTION.
---FEVER MAY BE DUE TO ANOTHERV REASON, NOT
THE POSITIVE CULTURE….
TENET-2
DO
NOT
TREAT
STERILE INFLAMMATION
OR
ABNORMAL IMAGING
WITHOUT
INFECTION
X-RAYS CAN BE DIFFICULT TO
INTERPRIT
INFILTRATE MAY BE DUE TO
NON-INFECTIOUS CAUSE
TENET-3
DO NOT
USE
ANTIBIOTICS TO TREAT VIRAL
INFECTIONS
THERE IS NO DEFINITE PROOF
THAT
ANTIBIOTICS CAN PREVENT
SECONDARY INFECTION
TENET-4
A
GOOD
ANTIBIOTIC
DOES NOT NECESSARILY MEANS
A
COSTLY
ANTIBIOTIC.
TO SUMMARISE
-THERE IS A GREAT NEED OF NEWER
ANTIBIOTICS BECAUSE OF INCREASING
MICRIBIAL RESISTANCE.
-BECAUSE OF GREAT COST OF DEVELOP-
MENT ONLY FEW DRUGS ARE IN PIPELINE.
-RATIONAL USE OF ANTIBIOTICS REMAINS
THE MOST IMPORTANT MEASURE.
THANK YOU

Principles of Antibiotic Use in ICU

  • 1.
    PRINCIPLES OF ANTIBIOTIC USEIN ICU Dr. R.K.Sisodia Senior Consultant Critical care Kailash Hospital Ltd Greater Noida
  • 2.
    INTRODUCTION- --THE MODERN AGEOF ANTIBIOTIC THERAPEUTICS WAS LAUNCHED IN 1930S WITH SULPHONAMIDES AND IN 1940S WITH PENICILLINS. --SINCE THEN MANY ANTIBIOTIC DRUGS HAVE BEEN DEVELOPED MOSLTY AIMED AT THE TREATMENT OF BACTERIAL INFECTIONS.
  • 3.
    --THESE DRUGS HAVEPLAYED AN IMPORTANT ROLE IN THE DRAMATIC DECREASE IN THE MORBADITY AND MORTALITY DUE TO INFECTIOUS DISEASES. --WHILE THE ABSOLUTE NUMBER OF ANTIBIOTIC DRUGS ARE LARGE, THERE ARE FEW UNIQUE ANTIBIOTIC TARGETS
  • 4.
    DEFINATION ANTIBIOTICS ARE THE TYPESOF MEDICATION THAT DESTROYS OR SLOWS DOWN THE GROWTH OF BACTERIA
  • 5.
    QUALITIES OF AGOOD ANTIBIOTIC AGENT -KILL OR INHIBIT THE GROWTH OF MICROORGANISM. -CAUSE NO DAMAGE TO THE HOST. -CAUSE NO ALLERGIC REACTION TO THE HOST. -STABLE ON STORAGE. -REMAIN IN SPECIFIC TISSUE ENOUGH TO BE EFFECTIVE. -KILL THE PATHOGEN BEFORE THEY MUTATE AND BECOME RESISTANT TO IT.
  • 6.
    WITHIN THE LAST15 YEARS A VARIETY OF NEW ANTIBIOTICS HAS BEEN INTRODUCED FOR USE IN CLINICAL PRACTICE BUT THE IDEAL ANTIBIOTIC MAY STILL BE IN FUTURE…
  • 7.
    MAIN ANTIBIOTICS USEDIN ICU DESPITE THE AVAILABILITY OF NUMEROUS ANTIBIOTICS, MOST PATHOGENS ARE OPTIMALLY TREATED WITH ONLY A FEW DRUGS
  • 8.
    THESE ARE ABROAD CLASS OF ANTIBIOTICS THAT CONTAIN A BETA LACTUM RING IN THEIR MOLECULAR STRUCTURE… Ex- PENICILLINS CEPHALOSPORINS CARBAPENUMS MONOBECTUMS BETA LACTAMS:
  • 9.
    --BETA LACTUM ANTIBIOTICSARE THE MOST WIDELY USED GROUP OF ANTIBIOTICS, --BACTERIA OFTEN DEVELOP RESISTANCE BY SYNTHESIZING A BETA LACTAMASE, AN ENZYME THAT ATTACKS BETA LACTUM RING --TO OVERCOME THIS RESISTANCE THESE ANTIBIOTICS ARE PRESCRIBED WITH THE BETA LACTUM INHIBITORS…
  • 10.
    PENICILLINS NATURAL PENICILLINS- Ex- BENZYLPENICILLINS -PHENOXYMETHYLPENICILLIN SEMISYNTHETICPENICILLINS 1-ANTISTAPHYLOCOCCI PENICILLINASE RESISTANT PENICILLIN Ex- OXACILLIN, DICLOXACILLIN,METHICILLIN 2-ANTIPSEUDOMONAS PENICILLINS Ex-PIPERACILLIN 3-WIDE SPECTRUM Ex-AMPICILLIN, AMOXICILLIN
  • 11.
    BETA LACTAMASE INHIBITORS -CLAVULANICACID -SULBACTAM -TAZOBACTAM
  • 12.
    BETA-LACTAMASE PROTECTED PENICILLINS AMOXICILLIN /CLAVULANATE AMPICILLIN / SUBACTUM TICARCILLIN / CLAVULANATE PIPERACILLIN / TAZOBACTUM
  • 13.
  • 14.
  • 15.
    CEPHALOSPORINES ARE NOT RECOMMONDEDTO COMBINE WITH OTHER NEPHROTOXIC DRUGS (AMINOGLYCOSIDES) CEPHALOSPORINES ARE CONTRADICTED TO COMBINE WITH LOOP DIURETICS...
  • 16.
    CARBAPENUMS: ACT BY INHIBITINGTHE CELL WALL SYNTHESIS AND ARE KNOWN TO BE MOST EFFECTIVE AGAINST GRAM NEGATIVE INFECTION. Ex- IMIPENUM MERUPENUM DORIPENUM ERTAPENUM
  • 17.
    THE WIDEST SPECTRUMOF ANTIBACTERIAL ACTION MOST OF AEROBE AND ANAEROBE, GRAM +VE AND GRAM –VE BACTERIA INCLUDING THOSE WHICH PRODUCE BETA-LACTAMASE
  • 18.
    FLOUROQUINILONES: EXERT THEIR ANTIBACTERIALEFFECT BY PREVENTING BACTERIAL DNA FROM DUPLICATIONG. Ex-CIPROFLOXACIN -LEVOFLOXACIN -OFLOXACIN -PAZUFLOXACIN -SPARFLOXACIN -MOXIFLOXACIN
  • 19.
    MACROLIDES: -THE MECHANISM OFACTION OF MACROLIDES IS INHIBITION OF BACTERIAL PROTEIN BIOSYNTHESIS. -THIS ACTION IS BACTEROSTATIC.
  • 20.
    CLASSIFICATION OF MACROLIDES 1-NATURAL SUBSTANCES Ex- ERYTHROMYCIN 2- SEMI-SYNTHETIC SUBSTANCES Ex-CLARITHROMYCIN 3- AZALIDE Ex- AZITHROMYCIN
  • 21.
    AMINOGLYCOSIDES: -MAINLY GRAM NEGATIVEBACTERICIDAL AGENT WORK BY INHIBITING PROTEIN BIOSYNTHESIS. 1st GENERATION- Ex-STREPTOMYCIN, NEOMYCIN,KENAMYCIN 2ND GENERATION- Ex-GENTAMICIN, TOBRAMYCIN 3RD GENERATION- Ex- AMIKACIN, NETILMICIN
  • 22.
    GLYCOPEPTIDES: - THESE DRUGSINHIBIT THE SYNTHESIS OF CELL WALL. - DUE TO TOXICITY THEIR USE IS RESTRICTED TO PATIENTS WHO HAVE HYPERSENSITIVE TO BETA LACTUMS. - EFFECTIVE MAINLY AGAINT GRAM POSITIVE COCCI. Ex- VANCOMYCIN - TEICOPLANIN
  • 23.
    MONOBACTUM- AZTREONUM - -ACTION SPECTRUM-GRAM NEGATIVE BACTERIA INCLUDING E-COLI, KLEBSIELLA. HAEMOPHILLUS INFLUEZAE… -ACTIVITY EQUAL TO 3RD GENERATION CEPHALOSPORINES… -CLINCAL USES- SEPSIS, UTI, SSTI, MENINGITIS -OFTENCOMBINEAMINOGLYCOSIDES, CLINDAMYCIN, METRONIDAZOLE,VANCOMYCIN….
  • 24.
    LINCOSAMIDES- CLINDAMYCIN -ACTION SPECTRUM: GRAM+VE AEROBICCOCCI, GRAM+VE & GRAM –VE ANAEROBES -PENETRATE ALL THE TISSUES -A LOT OF SIDE EFFECTS
  • 25.
  • 26.
    ACCORDING TO ACTIVITY1-BACTERICIDAL: THEYKILL BACTERIA DIRECTLY. Ex- BETA LACTUMS CEPHALOSPORINS CARBAPENUMS AMINOGLYCOSIDES....... 2-BACTERIOSTATIC: THEY STOP BACTERIA FROM GROWING. Ex- TETRACYCLINE CHLORAMPHENICOL SULPHONAMIDES MACROLIDES LINCOSAMIDES
  • 27.
    ACCORDING TO SPECTRUM 1-BROADSPECTRUM: THEY WORK AGAINST VARIETY OF BACTERIA Ex:- PENICILLINS CARBAPENUMS FLOROQUINILONES CEPHALOSPORINS............... 2-NARROW SPECTRUM: THEY WORK AGAINST A SMALL RANGE OF BACTERIA Ex:- MACROLIDES LINCOSAMIDES GLYCOPEPTIDES.........
  • 28.
    ACCORDING TO MECHANISM OFACTION 1-CELL WALL SYNTHESIS INHIBITORS: Ex:- PENICILLINS CEPHALOSPORINS BETA LACTUMS CARBAPENUMS MACROLIDES VANCOMYCIN........
  • 29.
    2- PROTEIN SYNTHESISINHIBITORS: A-INHIBIT 30S SUBUNIT:- Ex- AMINOGLYCOSIDES TETRACYCLINE B-INHIBIT 50S SUBUNIT:- Ex- MACROLIDES - CHLORAMPHENICOL - CLINDAMYCIN - LINEZOLID
  • 30.
    3- DNA SYNTHESISINHIBITORS: Ex- FLOROQUINOLONES - METRONIDAZOLE 4- RNA SYNTHESIS INHIBITORS: Ex- RIFAMPICIN 5- FOLIC ACID SYNTHESIS INHIBITORS: Ex- SULPHONAMIDES - TRIMETHOPRIM
  • 31.
    ACCORDING TO FREQUENCYOF DOSING 1- TIME DEPENDENT Ex- CARBAPENUMS - MACROLIDES - BETA LACTUMS 2- CONCENTRATION DEPENDENT Ex- AMINOGLYCOSIDES
  • 32.
    GLYCYLCYCLINES: TIGICYCLINE ---SPECTRUM INCLUDED GRAM+VEAND GRAM –VE AEROBIC AND ANAEROBIC BACTERIA,INCLUDING SOME WITH RESISTANT TO OTHER CLASSES e.g. VRE, MRSA AND MDR ACINETOBACTER. ---BUT HAS LIMITED ACTIVITY AGAINST P. AERUGINOSA.
  • 33.
    RIGHT TIME 1- EMPIRICALLY- FORPRESUMED INFECTION WITH CULTURE REPORT PENDING. 2- PROPHYLECTALLY- MAINLY PEROPERATIVELY TO PREVENT INFECTION. 3-DEFINITIVELY- WITH POSITIVE CULTURE REPORT.
  • 34.
    EMPIRICAL ANTIBIOTIC THERAPY -IN CRITICALLY ILL PATIENTS, EMPIRICAL ANTIBIOTIC THERAPY SHOULD BE INITIATED IMMEDIATELY OR CONCURRENTLY WITH COLLECTION OF DIAGNOSTIC SPECIMENS.
  • 35.
    GUIDELINES EMPIRICAL ANTIBIOTIC THERAPY 1-SITE OF INFECTION 2- PATIENT'S FACTORS RENAL HEPATIC IMMUNE SYSTEM AGE 3-SEFTY OF ANTIBIOTIC 4-COST OF THERAPY
  • 36.
    USING ANTIBIOTICS RESPONSIBILY RIGHTDOSE WITH RIGHT FREQUENCY: MONOTHERAPY OR COMBINATION THERAPY
  • 37.
    ADVANTAGES OF COMBINATION THERAPY 1- PREVENTIONOF DEVELOPMENT OF ANTIBIOTIC RESISTANCE. 2- ACHIEVING ANTIBIOTIC SYNERGISM Ex- SULPHONAMIDE+ TRIMETHOPRIM - VANCOMYCIN+ AMINOGLYCOSIDE 3- WIDE ANTIBIOTIC COVERAGE 4- DECREASED INCIDENCE OF TOXICITY
  • 38.
    GENERAL PRINCILES OFANTIBIOTIC THERAPY USING ANTIBIOTICS RESPONSIBLY RIGHT DRUG RIGHT TIME RIGHT DOSE RIGHT DURATION
  • 39.
    DISADVANTAGES OF COMBINATION THERAPY 1-INCREASED COST OF THERAPY. 2- MORE CHANCES OF SUPERINFECTION. 3- DRUG ANTAGONISM Ex- IF TWO BETA LACTUMS GIVEN TO GETHER ONE WILL BECOME INEFFECTIVE 4- DIRECT INTERACTION OF DRUGS. Ex- MIXING TICARCILLIN WITH AMONO- GLYCOSIDE RESULTS IN INACTIVATION OF AMINOGLYCOSIDE.
  • 40.
    USING ANTIBIOTICS RESPONSIBLY TIMEDEPENDENT OR CONCENTRATION DEPENDENT
  • 41.
    TIME DEPENDENT DOSING THOSECLASSES OF ANTIBIOTICS WHOSE KILLING RESPONSE IS DEPENDENT ON TIME ARE TERMED AS TIME DEPENDENT ANTIBIOTICS. HIGHER CONCENTRATION OF SUCH DRUGS DOES NOT RESULTS IN HIGHER KILLING OF BACTERIA. Ex- CARBAPENUMS - PENICILLINS - CEPHALOSPORINS.......
  • 42.
    CONCENTRATION DEPENDENT DOSING THOSECLASSES OF ANTIBIOTICS WHICH EREDICATE BACTERIA BY ACHIEVING HIGH CONCENTRATION AT THE SITE OF BONDING IS KNOWN AS CONCENTRATION DEPENDENT ANTIBIOTICS. Ex- AMINOGLYCOSIDES FLOUROQUINOLONES
  • 43.
    USING ANTIBIOTICS RESPONSIBLY RIGHTDURATION OF THERAPY ASCALATION OR DEASCALATION THERAPY
  • 44.
    ASCALATION OR TRADITIONAL APPROACH TRADITIONALAPPROACH TO ANTIBIOTIC THERAPY SUGGESTS THAT YOU SHOULD CHOOSE THE NARROWEST SPECTRUM ANTIBIOTIC AGAINST THE BACTERIA YOU SUSPECT ARE CAUSING THE INFECTION. THIS WOULD THEN BE MODIFIED BASED ON DEFINITIVE CULTURE RESULTS.
  • 45.
  • 46.
    CENTRAL NERVOUS SYSYEM MENINGITIS; CEFTRIAXONE-2 GM IV q12h + VANCOMYCIN- 500-750 MG IV q6h ALTERNATIVE MERUPENUM 2 GM IV q8h POST HEAD TRAUMA: CEFEPIME 2 GM IV q8h + VANCOMYCIN 500-750 MG IV q6h ALTERNATIVE MERUPENUM 2 GM IV q8h VANCOMYCIN 1 GM IV q6-8h
  • 47.
    PNEUMONIA COMMUNITY ACQUIRED: CEFTRIAXONE 1GM IV q12h + AZITHROMYCIN 500 MG IV q24h OR ERTAPENUM 1 GM IV q24h + AZITHROMYCIN 500 MG IV q24h
  • 48.
    PNEUMONIA HOSPITAL ACQUIRED: IMIPENUM- 500MG IV q6h OR MERUPENAM- 1 GM IV q8h OR DORIPENUM- 500 MG IV q8h + LEVO 750 MG IV q24h OR MOXI 400 MG IV q24h
  • 49.
    ASPIRATION PNEUMONITIS: -PIP+TAZO 4.5GM IV q8h ALTERNATIVE CEFTRIAXONE 1 GM IV q12h + METRONIDAZOLE 500 MG IV q8h
  • 50.
    PERITONITIS SPONTANEOUS BACTERIAL PERITONITIS CEFOTAXIME2 GM IV q8h OR PIP+TAZO 4.5GM IV q8h OR CEFTRIOXONE 2GM IV q8h OR ERTAPENUM 1GM IV q24h
  • 51.
    PERITONITIS PERFORATION PERITONITIS PIP+TAZO 4.5GMIV q8h OR ERTAPENUM 1GM IV q24h LIFE THREATENING PERITONITIS IMIPENUM 500MG IV q8h OR MERUPENUM 1GM IV q8h OR DORIPENUM 500MG IV q8h
  • 52.
    BURN WOUND SEPSIS- PIP+TAZO4.5GM IV q8h + VANCOMYCIN 1 GM IV q12h + AMIKACIN 7.5GM / KG IV q12h
  • 53.
    BONE AND JOINTINFECTION: --FLUCLOXACILLIN 2 GM IV q8h IF ALLERGIC TO PINICILLINS --CEFUROXIME 2GM IV q8h OR ---CLINDAMYCIN 600MG IV q6h IF MRSA IS A POSSIBILITY ---PIP+TAZO 4.5GM IV q8h + ----VANCOMYCIN 1GM IV q8h IF RISK OF MDRGNB ---MERUPENUM 1GM IV q8h
  • 54.
    TYPHOIDAL SYNDROME CIPROFLOX 500MGIV q12h OR LEVOFLOX 500 MG IV q12h OR CEFTRIAXONE 2 GM IV q8h OR AZITHROMYCIN 500 MG PO q24h
  • 55.
    INAPPROPRIATE USE OFANTIBIOTICS IS A WORLD WIDE PROBLEM * MORE THAN 50% OF ALL MEDICINES ARE PRESCRIBED,DISPENSED OR SOLD INAPPROPRIATELY. * HALF OF ALL PATIENTS FAIL TO TAKE MEDICINES CORRECTLY. *THE OVERUSE,UNDER USE OR MISUSE HARM PEOPLE AND WASTE RESOURSES. *MORE THAN 50% OF ALL COUNTRIES DO NOT IMPLEMENT BASIC POLICIES TO PROMOTE RATIONAL USE OF MEDICINES. *LESS THAN 30% OF ALL PATIENTS ARE TREATED ACCORDING TO CLINICAL GUIDELINES.
  • 56.
    WHAT WENT WRONGWITH ANTIBIOTIC USES -TREATING TRIVIAL / VIRAL INFECTIONS WITH ANTIBIOTICS HAS BECOME ROUTINE. - MANY USE ANTIBIOTICS WITHOUT KNOWING THE BASIC PRINCIPLES OF ANTIBIOTIC THERAPY. - MANY PRACTIONERS ARE UNDER PRESSURE FOR SHORT TERM SOLUTIONS. -EMERGING RESISTANCE DUE TO UNAPPROPRIATE USE OF ANTIBIOTICS. -COMMERCIAL INTERESTS OF PHARMACEUTICAL INDUSTRY PUSHING THE USE OF ANTIBIOTICS.
  • 57.
    NEED FOR NEWER ANTIBIOTICS NEWERANTIBIOTICS ARE NEEDED DESPERATELYBECAUSE: -- EMERGENCE BACTERIAL RESISTANCE --RESERGENCE AND NEW INFECTIOUS DISEASES
  • 58.
    SINCE 2000 ONLY 3NEW CLASSES OF ANTIBIOTICS HAVE BEEN INTRODUCED FOR HUMAN USE..
  • 59.
    NEW CLASSES OFANTIBIOTICS: 1- OXAZOLIDIONE LINEZOLID: -APPROVED FOR ADULT USE IN 2000. -NEWER OXAZOLIDIONE IN PIPELINE. RADEZOLID TOREZOLID
  • 60.
    NEWER CLASSES OFANTIBIOTICS 2-LIPOPEPTIDES -DEPTOMYCIN APPROVED IN 2003 RAPIDLY BACTERICIDAL NO CROSS RESISTANCE
  • 61.
    NEWER CLASSES OFANTIBIOTICS 3-KETOLIDES TELITHROMYCIN -APPROVED IN 2004 -FOR COMMUNITY ACCQUIRED PNEUMONIA
  • 62.
  • 63.
    - REDUCE THEANTIBIOTIC RESISTANCE - INITIATE BEST EFFORTS IN THE HOSPITAL AREA AS MANY RESISTANCE BACTERIA GENERATED IN HOSPITALS. -INITIATE GOOD HYGIENIC PRACTICES SO BACTERIA DO NOT SPREAD. -PRACTICE BEST EFFORTS TO PREVENT SPREAD OF RESISTANT STRAINS. -TO PREVENT SPILL INTO SOCIETY AS THEY PRESENT AS COMMUNITY ACQIURED INFECTIONS.
  • 64.
    A MEDICAL DOCTORHAS TO KNOW DEFINITE CLINICAL PHARMACOLOGY OF ANTIBIOTICS HOW TO SELECT AND USE THEM RATIONALLY
  • 65.
  • 66.
  • 67.
    MANY PATIENTS BECOMECOLONIZED WITH POTENTIALLY PATHOGENIC BACTERIA BUT ARE NOT INFECTED- --ASYMPTOMATIC BACTERIURIA OR CATHETER COLONIZATION. ---TRACHEOSTOMY COLONIZATION. ---CHRONIC WOUNDS. ---CHRONIC BRONCHITIS. ---PRESENCE OF WBC NOT ALWAYS INDICATIVE OF INFECTION. ---FEVER MAY BE DUE TO ANOTHERV REASON, NOT THE POSITIVE CULTURE….
  • 68.
  • 69.
    X-RAYS CAN BEDIFFICULT TO INTERPRIT INFILTRATE MAY BE DUE TO NON-INFECTIOUS CAUSE
  • 70.
    TENET-3 DO NOT USE ANTIBIOTICS TOTREAT VIRAL INFECTIONS THERE IS NO DEFINITE PROOF THAT ANTIBIOTICS CAN PREVENT SECONDARY INFECTION
  • 71.
  • 72.
    TO SUMMARISE -THERE ISA GREAT NEED OF NEWER ANTIBIOTICS BECAUSE OF INCREASING MICRIBIAL RESISTANCE. -BECAUSE OF GREAT COST OF DEVELOP- MENT ONLY FEW DRUGS ARE IN PIPELINE. -RATIONAL USE OF ANTIBIOTICS REMAINS THE MOST IMPORTANT MEASURE.
  • 73.